GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (FRA:0V0) » Definitions » Enterprise Value

Vimian Group AB (FRA:0V0) Enterprise Value : €2,027.3 Mil (As of May. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Vimian Group AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vimian Group AB's Enterprise Value is €2,027.3 Mil. Vimian Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was €51.5 Mil. Therefore, Vimian Group AB's EV-to-EBIT ratio for today is 39.35.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vimian Group AB's Enterprise Value is €2,027.3 Mil. Vimian Group AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €85.9 Mil. Therefore, Vimian Group AB's EV-to-EBITDA ratio for today is 23.59.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vimian Group AB's Enterprise Value is €2,027.3 Mil. Vimian Group AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was €391.0 Mil. Therefore, Vimian Group AB's EV-to-Revenue ratio for today is 5.18.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Vimian Group AB's Enterprise Value is €2,027.3 Mil. Vimian Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was €50.5 Mil. Therefore, Vimian Group AB's EV-to-FCF ratio for today is 40.13.


Vimian Group AB Enterprise Value Historical Data

The historical data trend for Vimian Group AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Enterprise Value Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial - 2,998.38 1,263.45 1,481.92 1,988.06

Vimian Group AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,484.82 1,708.60 2,292.20 1,988.06 2,240.45

Competitive Comparison of Vimian Group AB's Enterprise Value

For the Diagnostics & Research subindustry, Vimian Group AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vimian Group AB's Enterprise Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's Enterprise Value falls into.


;
;

Vimian Group AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Vimian Group AB's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Vimian Group AB's Enterprise Value for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB  (FRA:0V0) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Vimian Group AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2027.323/51.515
=39.35

Vimian Group AB's current Enterprise Value is €2,027.3 Mil.
Vimian Group AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €51.5 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Vimian Group AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2027.323/85.947
=23.59

Vimian Group AB's current Enterprise Value is €2,027.3 Mil.
Vimian Group AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €85.9 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Vimian Group AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2027.323/391.038
=5.18

Vimian Group AB's current Enterprise Value is €2,027.3 Mil.
Vimian Group AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €391.0 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Vimian Group AB's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2027.323/50.519
=40.13

Vimian Group AB's current Enterprise Value is €2,027.3 Mil.
Vimian Group AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €50.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.

Vimian Group AB Headlines

No Headlines